Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by33

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by25

Views

Views
January 20251
February 20250
March 202510
April 20252
May 20251
June 202510
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore10
Hong Kong9
United States4
Spain1
Mexico1
 

Top cities views

Views
Hong Kong9
Council Bluffs1
Los Angeles1
Mexico City1
Minneapolis1